Evidence map›Paper›PMID 33176676›Full record

ArticleBMC bioinformatics2020

Performance of copy number variants detection based on whole-genome sequencing by DNBSEQ platforms.

Junhua Rao, Lihua Peng, Xinming Liang, Hui Jiang, Chunyu Geng, Xia Zhao, Xin Liu, Guangyi Fan, Fang Chen, Feng Mu

Abstract read
In one paragraph

Article in BMC bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Junhua RaoMGI, BGI-Shenzhen, Shenzhen, 518083, China.
Lihua PengBGI-Shenzhen, Shenzhen, 518083, China.
Xinming LiangMGI, BGI-Shenzhen, Shenzhen, 518083, China.
Hui JiangMGI, BGI-Shenzhen, Shenzhen, 518083, China.
Chunyu GengMGI, BGI-Shenzhen, Shenzhen, 518083, China.
Xia ZhaoMGI, BGI-Shenzhen, Shenzhen, 518083, China.
Xin LiuBGI-Shenzhen, Shenzhen, 518083, China.
Guangyi FanBGI-Qingdao, BGI-Shenzhen, Qingdao, 266555, Shandong, China.
Fang ChenMGI, BGI-Shenzhen, Shenzhen, 518083, China. fangchen@genomics.cn.ORCID http://orcid.org/0000-0002-7095-0541
Feng MuMGI, BGI-Shenzhen, Shenzhen, 518083, China. mufeng@genomics.cn.

Funding

the Key R&D Program of Guangdong Province 2019B020226001the National Key R&D Program of China 2017YFC0906500
6 · The paper itself

Abstract

backgroundDNBSEQ™ platforms are new massively parallel sequencing (MPS) platforms that use DNA nanoball technology. Use of data generated from DNBSEQ™ platforms to detect single nucleotide variants (SNVs) and small insertions and deletions (indels) has proven to be quite effective, while the feasibility of copy number variants (CNVs) detection is unclear.

resultsHere, we first benchmarked different CNV detection tools based on Illumina whole-genome sequencing (WGS) data of NA12878 and then assessed these tools in CNV detection based on DNBSEQ™ sequencing data from the same sample. When the same tool was used, the CNVs detected based on DNBSEQ™ and Illumina data were similar in quantity, length and distribution, while great differences existed within results from different tools and even based on data from a single platform. We further estimated the CNV detection power based on available CNV benchmarks of NA12878 and found similar precision and sensitivity between the DNBSEQ™ and Illumina platforms. We also found higher precision of CNVs shorter than 1 kbp based on DNBSEQ™ platforms than those based on Illumina platforms by using Pindel, DELLY and LUMPY. We carefully compared these two available benchmarks and found a large proportion of specific CNVs between them. Thus, we constructed a more complete CNV benchmark of NA12878 containing 3512 CNV regions.

conclusionsWe assessed and benchmarked CNV detections based on WGS with DNBSEQ™ platforms and provide guidelines for future studies.

Indexed as

Polymorphism, Single NucleotideDatabases, GeneticDNA Copy Number VariationsGenome, HumanHigh-Throughput Nucleotide SequencingHumansWhole Genome SequencingBenchmarkCopy number variant (CNV)DNBSEQWhole-genome sequencing (WGS)

Identifiers

PMID33176676
PMCPMC7659224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.